{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:12:53Z","timestamp":1778904773736,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clgc.2026.102559","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:50:32Z","timestamp":1776174632000},"page":"102559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiologic and Pathologic Concordance of Multiparametric MRI for Detecting Unilateral Prostate Cancer: Implications for Focal Therapy Selection"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-7093","authenticated-orcid":false,"given":"Miguel Angel","family":"Rodr\u00edguez-Cabello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"M\u00e9ndez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"V\u00e1zquez-Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Sanz-Miguela\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernabe","family":"Pozo-Mengual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-4295","authenticated-orcid":false,"given":"Arturo","family":"Platas-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2026.102559_bib0001","unstructured":"International Agency for Research on Cancer. Prostate Source: Globocan 2020 Number of New Cases in 2020, Both Sexes, All Ages. 2020 Available at: https:\/\/gco.iarc.fr\/today Accessed: December 4, 2022;1-2."},{"key":"10.1016\/j.clgc.2026.102559_bib0002","article-title":"Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses","volume":"13","author":"Zhao","year":"2025","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102559_bib0004","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s00120-016-0264-5","article-title":"TNM-classification of localized prostate cancer : the clinical T-category does not correspond to the required demands","volume":"55","author":"Herden","year":"2016","journal-title":"Urologe A"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0006","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0007","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4","article-title":"Staging prostate cancer","volume":"51","author":"Hoedemaeker","year":"2000","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.clgc.2026.102559_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rcl.2023.06.010","article-title":"Prostate cancer local staging with magnetic resonance imaging","volume":"62","author":"Lin","year":"2024","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0009","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1148\/radiol.2019182946","article-title":"PI-RADS Steering Committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway","volume":"292","author":"Padhani","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clgc.2026.102559_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2026.102559_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-022-03444-1","article-title":"Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions","author":"Bogner","year":"2022","journal-title":"Abdom Radiol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5152\/tud.2023.22261","article-title":"Staging of prostate cancer: role of multiparametric magnetic resonance imaging in different risk classes","volume":"49","author":"Guerra","year":"2023","journal-title":"Urol Res Pract"},{"key":"10.1016\/j.clgc.2026.102559_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.urology.2020.08.089","article-title":"Multiparametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification","volume":"147","author":"Soeterik","year":"2021","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0014","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","article-title":"The role of focal therapy in the management of localised prostate cancer: a systematic review","volume":"66","author":"Valerio","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102559_bib0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41391-024-00907-y","article-title":"Identifying the best candidate for focal therapy: a comprehensive review","volume":"28","author":"Ghoreifi","year":"2025","journal-title":"Prostate Cancer Prostat Dis"},{"issue":"7","key":"10.1016\/j.clgc.2026.102559_bib0016","doi-asserted-by":"crossref","first-page":"637.e1","DOI":"10.1016\/j.urolonc.2020.01.005","article-title":"Validation of the updated eighth edition of AJCC for prostate cancer: removal of pT2 substages\u2014does extent of tumor involvement matter?","volume":"38","author":"Pompe","year":"2020","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0017","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.juro.2017.12.056","article-title":"Does subclassification of pathologically organ confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?","volume":"199","author":"Nguyen","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0018","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102559_bib0019","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00345-023-04444-6","article-title":"Factors affecting the selection of eligible candidates for focal therapy for prostate cancer","volume":"41","author":"Takeda","year":"2023","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.prnil.2022.12.003","article-title":"Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy","volume":"11","author":"Choi","year":"2023","journal-title":"Prostate Int"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0021","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102559_bib0022","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/pcan.2017.8","article-title":"Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project","volume":"20","author":"Tay","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.clgc.2026.102559_bib0023","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOU.0000000000000976","article-title":"Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer","volume":"32","author":"Jaipuria","year":"2022","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0024","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.01.001","article-title":"Focal therapy in prostate cancer: international multidisciplinary consensus on trial design","volume":"65","author":"Van Den Bos","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.56434\/j.arch.esp.urol.20227504.47","article-title":"Comparative study between 1.5 and 3 tesla multiparametric MRI systems using the PIRADS version 2 classification in the diagnosis of prostate cancer","volume":"75","author":"Cabello","year":"2022","journal-title":"Arch Esp Urol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102559_bib0026","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.crad.2019.05.019","article-title":"PI-RADS version 2.1: one small step for prostate MRI","volume":"74","author":"Barrett","year":"2019","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102559_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13244-023-01422-9","article-title":"Imaging features of the PI-RADS for predicting extraprostatic extension of prostate cancer: systematic review and meta-analysis","volume":"14","author":"Choi","year":"2023","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2026.102559_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinimag.2019.08.007","article-title":"T-staging of prostate cancer: identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI","volume":"59","author":"Pesapane","year":"2020","journal-title":"Clin Imaging"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/apm.12533","article-title":"International Society of Urological Pathology (ISUP) grading of prostate cancer\u2014an ISUP consensus on contemporary grading","volume":"124","author":"Egevad","year":"2016","journal-title":"Apmis"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0031","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0032","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.eururo.2020.08.004","article-title":"The 2019 International Society of Urological Pathology Consensus Conference on prostate cancer grading","volume":"79","author":"van Leenders","year":"2021","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102559_bib0033","doi-asserted-by":"crossref","first-page":"929.e11","DOI":"10.1016\/j.urolonc.2020.05.027","article-title":"Pathological findings at radical prostatectomy of biopsy na\u00efve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling","volume":"38","author":"Luzzago","year":"2020","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0034","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00428-006-0254-x","article-title":"Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)","volume":"449","author":"Van Der Kwast","year":"2006","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.clgc.2026.102559_bib0035","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00345-019-02634-9","article-title":"A multicentric study on accurate grading of prostate cancer with systematic and MRI\/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy","volume":"37","author":"Diamand","year":"2019","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0036","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41391-023-00714-x","article-title":"Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches","volume":"27","author":"Hagens","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0037","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/curroncol29040193","article-title":"Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer","volume":"29","author":"Humke","year":"2022","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102559_bib0038","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6434-2","article-title":"Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate cancer: a systematic review and meta-analysis","volume":"19","author":"Zhen","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102559_bib0039","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102559_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes\u2014a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0041","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00345-016-1960-x","article-title":"Multiparametric magnetic resonance imaging for prostate cancer\u2014a comparative study including radical prostatectomy specimens","volume":"35","author":"Toner","year":"2016","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0042","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00345-016-1948-6","article-title":"Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy","volume":"35","author":"Lee","year":"2016","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0043","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.01.001","article-title":"Focal therapy in prostate cancer: international multidisciplinary consensus on trial design","volume":"65","author":"Van Den Bos","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2026.102559_bib0044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000357121","article-title":"Bilaterally positive biopsy cores are associated with non-organ-confined disease in prostate cancer patients eligible for active surveillance","volume":"93","author":"Umbehr","year":"2014","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0045","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0022-5347(05)65077-X","article-title":"Percent of cancer in the biopsy set predicts pathological findings after prostatectomy","volume":"167","author":"Grossklaus","year":"2002","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102559_bib0046","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S1677-5538.IBJU.2014.01.03","article-title":"Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study","volume":"40","author":"Miano","year":"2014","journal-title":"International Braz J Urol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102559_bib0047","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1007\/s00345-022-04157-2","article-title":"Value of magnetic resonance imaging\/ultrasound fusion prostate biopsy to select patients for focal therapy","volume":"40","author":"Ganzer","year":"2022","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0048","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00345-018-2238-2","article-title":"Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI","volume":"36","author":"Pompe","year":"2018","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102559_bib0049","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.juro.2017.12.056","article-title":"Does subclassification of pathologically organ confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?","volume":"199","author":"Nguyen","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102559_bib0050","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102559_bib0051","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4081\/aiua.2018.3.191","article-title":"Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system","volume":"90","author":"Antunes","year":"2018","journal-title":"Arch Ital Urol Androl"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:33:30Z","timestamp":1778902410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1558767326000595"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102559","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiologic and Pathologic Concordance of Multiparametric MRI for Detecting Unilateral Prostate Cancer: Implications for Focal Therapy Selection","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102559"}}